Study of Neoadjuvant Docetaxel and Cyclophosphamide in Locally Advanced or Node Positive Primary Breast Cancer With Companion Pharmacokinetic and Pharmacogenomic Analyses
Clinical trial NCT01540110 · COMPLETED
Trial details
- NCT number
- NCT01540110
- Sponsor
- National Cancer Centre, Singapore
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-08-11
- Primary completion
- 2015-10-20
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.